• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra

cafead

Administrator
Staff member
  • cafead   Jun 28, 2018 at 07:13: PM
via Last month, WorldMeds won a historic FDA approval for opioid withdrawal drug Lucemyra, but it needed a marketing partner to help roll it out. Valeant’s Salix has taken the job.

article source
 

<